Correction to: Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

HomeStrokeVol. 50, No. 12Correction to: Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association Free AccessCorrectionPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessCorrectionPDF/EPUBCorrection to: Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association Originally published25 Nov 2019https://doi.org/10.1161/STR.0000000000000215Stroke. 2019;50:e440–e441This article corrects the followingGuidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke AssociationIn the article by Powers et al, “Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association,” which published ahead of print on October 30, 2019, and appeared in the December 2019 issue of the journal (Stroke. 2019;50:e344-e418 doi: 10.1161/STR.0000000000000211), several corrections were needed.1. On page e344, the title page, an additional endorsement has been added. It reads, “Reviewed for evidence-based integrity and endorsed by the American Association of Neurological Surgeons and Congress of Neurological Surgeons.”2. On page e346, left hand column, first paragraph, the first sentence read, “…Section 3.7.4., Recommendation 5 resulted.” It has been updated to read, “…Section 3.7.2., Recommendation 2 resulted.”3. On page e353, in “1.7. Organization and Integration of Components” section, the recommendation table, Recommendation 3, the fourth sentence read, “Facilities are encouraged to define criteria that can be used to credential individuals who can perform safe and timely intra-arterial revascularization procedures.” It has been updated to read, “Facilities are encouraged to consider preestablished criteria that can be used to credential individuals who can perform safe and timely intra-arterial revascularization procedures such as those agreed on by the Committee for Advanced Subspecialty Training of the Society of Neurological Surgeons in conjunction with other professional societies.61a”4. On page e368, in “Table 8. Eligibility Recommendations for IV Alteplase in Patients With AIS,” in “Additional recommendations for treatment with IV alteplase for patients with AIS (COR IIa) And (COR IIb)” section, the “Recent MI” subsection, the third entry read “For patients presenting with AIS and a history of recent MI in the past 3 mo, treating the ischemic stroke with IV alteplase may reasonable if the recent MI was a STEMI involving the left anterior myocardium.† (COR IIb; LOE C-LD)§” It has been updated to read, “For patients presenting with AIS and a history of recent MI in the past 3 mo, treating the ischemic stroke with IV alteplase may be reasonable if the recent MI was a STEMI involving the left anterior myocardium.† (COR IIb; LOE C-LD)§”5. On page e373, in section “3.7. Mechanical Thrombectomy,” subsection “3.7.2. 0 to 6 Hours From Onset,” the following changes have been made:• Recommendation 5 from section “3.7.4. Technique” has been inserted and labeled as Recommendation 2.• In the knowledge byte section for renumbered Recommendation 2, the following changes have been made:∘ In the second paragraph, the fourth sentence has been deleted.∘ In the second paragraph, last sentence, the reference citation has been renumbered. The sentence has been updated to read, “No difference in recanalization rates or intracranial hemorrhage was found.192”∘ In the third paragraph, sixth sentence, the reference citation has been renumbered. The sentence has been updated to read, “Given its superiority design…to establish noninferiority.193∘ In the third paragraph, ninth sentence, the reference citation has been renumbered. The sentence has been updated to read, “A 90-day mRS score of aspiration alone group.194• Recommendation 2 has been renumbered as Recommendation 3.• In the knowledge byte section for renumbered Recommendation 3, third sentence, the reference citation has been renumbered. The sentence has been updated to read, “In an analysis of pooled data…excellent functional outcomes (mRS score 0–1; OR, 2.2 [95% CI, 1.0–4.7]).195• Recommendation 3 has been renumbered as Recommendation 4.• Recommendation 4 has been renumbered as Recommendation 5.6. On page e374, in the “3.7.4. Technique” section, Recommendation 2 knowledge byte section, second sentence, the reference citation has been renumbered. The sentence has been updated to read, “A variety of reperfusion scores…predicting clinical outcomes.196,197”7. On page e375, in the “3.7.4. Technique” section,• Recommendation 5 and its knowledge byte section have been moved to become Recommendation 2 in the “3.7.2. 0 to 6 Hours From Onset” section.• Recommendation 6 has been renumbered as Recommendation 5.• Recommendation 7 has been renumbered as Recommendation 6.• Recommendation 8 has been renumbered as Recommendation 7.• Recommendation 9 has been renumbered as Recommendation 8.• Recommendation 10 has been renumbered as Recommendation 9.8. On page e404, in the References section, a new reference has been added. It reads, 61a. Day AL, Siddiqui AH, Meyers PM, Jovin TG, Derdeyn CP, Hoh BL, Riina H, Linfante I, Zaidat O, Turk A, Howington JU, Mocco J, Ringer AJ, Veznedaroglu E, Khalessi AA, Levy EI, Woo H, Harbaugh R, Giannotta S. Training standards in neuroendovascular surgery: program accreditation and practitioner certification. Stroke. 2017;48:2318-2325. doi: 10.1161/STROKEAHA.117.0165609. On page e408, in the References section, references 192 through 197 have been renumbered and reordered to read:192. Turk AS 3rd, Siddiqui A, Fifi JT, De Leacy RA, Fiorella DJ, Gu E, Levy EI, Snyder KV, Hanel RA, Aghaebrahim A, et al. Aspiration thrombectomy versus stent retriever thrombectomy as first-line approach for large vessel occlusion (COMPASS): a multicentre, randomised, open label, blinded outcome, non-inferiority trial. Lancet. 2019;393:998–1008. doi: 10.1016/S0140-6736(19)30297-1193. Lapergue B, Blanc R, Gory B, Labreuche J, Duhamel A, Marnat G, Saleme S, Costalat V, Bracard S, Desal H, et al; ASTER Trial Investigators. Effect of endovascular contact aspiration vs stent retriever on revascularization in patients with acute ischemic stroke and large vessel occlusion: the ASTER randomized clinical trial. JAMA. 2017;318:443–452. doi: 10.1001/jama.2017.9644194. Nogueira RG, Frei D, Kirmani JF, Zaidat O, Lopes D, Turk AS 3rd, Heck D, Mason B, Haussen DC, Levy EI, et al; Penumbra Separator 3D Investigators. Safety and efficacy of a 3-dimensional stent retriever with aspiration-based thrombectomy vs aspiration-based thrombectomy alone in acute ischemic stroke intervention: a randomized clinical trial. JAMA Neurol. 2018;75:304–311. doi: 10.1001/jamaneurol.2017.3967195. Lemmens R, Hamilton SA, Liebeskind DS, Tomsick TA, Demchuk AM, Nogueira RG, Marks MP, Jahan R, Gralla J, Yoo AJ, et al; DEFUSE 2, IMS III, STAR, and SWIFT Trialists; DEFUSE 2 IMS III STAR and SWIFT Trialists. Effect of endovascular reperfusion inrelation to site of arterial occlusion. Neurology. 2016;86:762–770. doi: 10.1212/WNL.0000000000002399196. Yoo AJ, Simonsen CZ, Prabhakaran S, Chaudhry ZA, Issa MA, Fugate JE, Linfante I, Liebeskind DS, Khatri P, Jovin TG, et al; for the Cerebral Angiographic Revascularization Grading Collaborators. Refining angiographic biomarkers of revascularization: improving outcome prediction after intra-arterial therapy. Stroke. 2013;44:2509–2512. doi: 10.1161/STROKEAHA.113.001990197. Marks MP, Lansberg MG, Mlynash M, Kemp S, McTaggart R, Zaharchuk G, Bammer R, Albers GW; DEFUSE 2 Investigators. Correlation of AOL recanalization, TIMI reperfusion and TICI reperfusion with infarct growth and clinical outcome. J Neurointerv Surg. 2014;6:724–728. doi: 10.1136/neurintsurg-2013-010973These corrections have been made to the current online version of the article, which is available at https://www.ahajournals.org/doi/10.1161/STR.0000000000000211. Previous Back to top Next FiguresReferencesRelatedDetailsCited By Bhatia V, Choudhary N, Prabhakar A, Kumar A and Khurana D (2022) Transbrachial access for mechanical thrombectomy in a case of acute ischemic stroke with aortic bifurcation occlusion, Journal of Stroke Medicine, 10.1177/25166085221089745, 5:1, (91-95), Online publication date: 1-Jun-2022. Mastrogiovanni M and Michelle Moccia J (2022) Optimizing handover in patients with stroke symptoms utilizing an organized protocol between emergency department providers and emergency medical personnel, International Emergency Nursing, 10.1016/j.ienj.2021.101129, 61, (101129), Online publication date: 1-Mar-2022. Foroughinia F, Morovati N, Safari A, Dianatpour M, Jamhiri I, Heydari S, Hooshmandi S and Borhani-Haghighi A (2022) Association between Fok1 and TaqI polymorphisms of vitamin D receptor gene with the severity of stenosis and calcification in carotid bulb in patients with ischemic stroke, Journal of Clinical Neuroscience, 10.1016/j.jocn.2022.01.009, 97, (115-120), Online publication date: 1-Mar-2022. 胡 素 (2022) Efficacy and Safety Evaluation of Argatroban and Fibrinolytic Enzyme in the Treatment of Progressive Perforator Artery Lesion Type Cerebral Infarction, Advances in Clinical Medicine, 10.12677/ACM.2022.124396, 12:04, (2764-2768), . Rajmohan R, Nguyen D, Miner N, Park S, Abcede H and Shafie M (2022) Possible synergism of tissue plasminogen activator and neurocysticercosis leading to intracranial hemorrhage, Brain Hemorrhages, 10.1016/j.hest.2022.04.001, Online publication date: 1-Apr-2022. Вишнева Е and Веснина Н (2021) Ишемический инсульт и covid‑19: механизмы патогенеза, клинические характеристики и трудности лечения в условиях пандемии, Естественные и Технические Науки, 10.37882/2223-2966.2021.04.11:№04, (185-192), . Kuryata O, Kushnir Y, Nedzvetsky V, Korsa V and Tykhomyrov A (2021) Serum Levels of the Biomarkers Associated with Astrocytosis, Neurodegeneration, and Demyelination: Neurological Benefits of Citicoline Treatment of Patients with Ischemic Stroke and Atrial Fibrillation, Neurophysiology, 10.1007/s11062-021-09907-3, 53:1, (2-12), Online publication date: 1-Jan-2021. Wang P, Sun Z, Yu J, Geng N, Liu L, Zhu L, Li J, Yuan H, Zhao G and Li Z (2021) Early argatroban and antiplatelet combination therapy in acute non-lacunar single subcortical infarct associated with mild intracranial atherosclerosis, BMC Neurology, 10.1186/s12883-021-02435-x, 21:1, Online publication date: 1-Dec-2021. Lee H, Yun H and Ding Y (2021) Timing is everything: Exercise therapy and remote ischemic conditioning for acute ischemic stroke patients, Brain Circulation, 10.4103/bc.bc_35_21, 7:3, (178), . Seiffge D, Meinel T, Purrucker J, Kaesmacher J, Fischer U, Wilson D and Wu T (2021) Recanalisation therapies for acute ischaemic stroke in patients on direct oral anticoagulants, Journal of Neurology, Neurosurgery & Psychiatry, 10.1136/jnnp-2020-325456, 92:5, (534-541), Online publication date: 1-May-2021. Uransilp N, Puengcharoen S and Muengtaweepongsa S (2021) Medical Management in Moyamoya Disease Moyamoya Disease - A Disease to Count On in Your Daily Practice, 10.5772/intechopen.95775 Venketasubramanian N (2021) Recurrent vascular events in ischaemic stroke patients with diabetes, Annals of the Academy of Medicine, Singapore, 10.47102/annals-acadmedsg.202136, 50:1, (3-4), Online publication date: 31-Jan-2021. 钟 介 (2021) Advances in the Study of Blood Pressure Management in Acute Phase of Ischemic Stroke Patients, Advances in Clinical Medicine, 10.12677/ACM.2021.111007, 11:01, (42-48), . Xu Z, Xu Y, Xie X, Tian Y, Sui J, Sun Y, Lin D, Gao X, Peng C and Fan Y (2021) Anti-platelet aggregation of Panax notoginseng triol saponins by regulating GP1BA for ischemic stroke therapy, Chinese Medicine, 10.1186/s13020-021-00424-3, 16:1, Online publication date: 1-Dec-2021. Gill R and Biller J (2021) Stroke Prevention in Cervical Artery Dissection, Current Cardiology Reports, 10.1007/s11886-021-01603-2, 23:12, Online publication date: 1-Dec-2021. Zhao L, Jian Y, Li T, Wang H, Lei Z, Sun M, Li Y, Zhang Y, Dang M, Huqing W, Hong S, Ru Z, Zhang H, Jia Y, Guogang L and Guilian Z (2020) The Safety and Efficiency of Tirofiban in Acute Ischemic Stroke Patients Treated with Mechanical Thrombectomy: A Multicenter Retrospective Cohort Study, Biochemistry Research International, 10.1155/2020/5656173, 2020, (1-8), Online publication date: 1-May-2020. Mushannen T, Aleyadeh R, Siddiqui M, Saqqur M, Akhtar N, Mesraoua B, Al Jerdi S, Melikyan G, Shaheen Y, Qadourah H, Chagoury O, Mahfoud Z and Haddad N (2021) Effect of Reperfusion Therapies on Incidence of Early Post-Stroke Seizures, Frontiers in Neurology, 10.3389/fneur.2021.758181, 12 Filev A and Pisarev V (2020) Cell-Free DNA in Emergency Medical Care, Russian Sklifosovsky Journal "Emergency Medical Care", 10.23934/2223-9022-2020-9-1-96-107, 9:1, (96-107) Halushko O (2021) Application of a free radical scavenger edaravone in patients with hemorrhagic stroke, Infusion & Chemotherapy, 10.32902/2663-0338-2021-1-28-36:1, (28-36) Pyatikop V, Kotlyarevsky Y and Sergienko Y (2020) Our experience in using of intravascular recanalization methods for treatment of acute ischemic stroke, Endovascular Neuroradiology, 10.26683/2304-9359-2020-2(32)-67-78, 32:2, (67-78) Bradley S, Varghese F, Menon B, Mehndiratta M and Bhaskar S (2021) Stroke in Patients with Diabetes: Is It Time to Expand Public Health Priority to Encompass High-Risk Patients with Increased Insulin Resistance?, EMJ Diabetes, 10.33590/emjdiabet/21-00171, (84-91) Spinul O, Kartashov O and Shpak O (2021) Possibility of increasing the «therapeutic window» for revascularization of the carotid arteries in the acute period of ischemic stroke, Ukrainian Interventional Neuroradiology and Surgery, 10.26683/2786-4855-2021-1(35)-43-49, 35:1, (43-49) Agaltsov M and Korostovtseva L (2021) Obstructive sleep apnea and cardiovascular comorbidity: modern discordance in assessing the effectiveness of CPAP-therapy against the pathogenetic mechanisms and cardiovascular diseases, PULMONOLOGIYA, 10.18093/0869-0189-2021-31-6-799-807, 31:6, (799-807) Han Z, Zhao W, Lee H, Wills M, Tong Y, Cheng Z, Dai Q, Li X, Wang Q, Geng X, Ji X and Ding Y (2021) Remote Ischemic Conditioning With Exercise (RICE)—Rehabilitative Strategy in Patients With Acute Ischemic Stroke: Rationale, Design, and Protocol for a Randomized Controlled Study, Frontiers in Neurology, 10.3389/fneur.2021.654669, 12 Ramazanov G, Kovaleva E, Klychnikova E, Kokov L, Korigova H, Muslimov R, Parkhomenko M, Petrikov S and Stepanov V (2021) Thrombectomy in patients with basilar artery thrombosis, Russian Sklifosovsky Journal "Emergency Medical Care", 10.23934/2223-9022-2021-10-3-484-492, 10:3, (484-492) Maksimova M and Airapetova A (2022) Possibilities of antiplatelet therapy in non-cardioembolic ischemic stroke, Neurology, Neuropsychiatry, Psychosomatics, 10.14412/2074-2711-2022-3-81-86, 14:3, (81-86) Usatov S, Rashidi B and Boguslavskiy Y (2021) To the issue of degree of removal of gliomas of supratentorial localization, Ukrainian Interventional Neuroradiology and Surgery, 10.26683/2786-4855-2021-1(35)-50-55, 35:1, (50-55) Kim C and Hladik A (2021) Angioedema Secondary to tPA Use in Acute Ischemic Stroke Patient with Hypertension: A Case Report, Clinical Practice and Cases in Emergency Medicine, 10.5811/cpcem.2021.1.49582, 2:5, (159-162) YAŞAR E (2022) PREDICTIVE VALUE OF C-REACTIVE PROTEIN/ALBUMİN RATIO IN THE DEVELOPMENT OF CONTRAST-INDUCED NEPHROPATHY IN PATIENTS WITH ACUTE ISCHEMIC STROKE TREATED PERCUTANEOUSLY, İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisi, 10.33715/inonusaglik.1028554 Zhang S, Jin T, Wang L, Liu W, Zhang Y, Zheng Y, Lin Y, Yang M, He X, Lin H, Chen L and Tao J (2020) Electro-Acupuncture Promotes the Differentiation of Endogenous Neural Stem Cells via Exosomal microRNA 146b After Ischemic Stroke, Frontiers in Cellular Neuroscience, 10.3389/fncel.2020.00223, 14 Sabaz M, Asar S, Cukurova Z, Sabaz N, Doğan H and Sertcakacilar G (2020) Effect of Delayed Admission to Intensive Care Units from the Emergency Department on the Mortality of Critically Ill Patients, Iranian Red Crescent Medical Journal, 10.5812/ircmj.102425, 22:6 Sharma R, Silverman S, Patel S, Schwamm L and Sanborn D (2022) Frequency, predictors and cardiovascular outcomes associated with transthoracic echocardiographic findings during acute ischaemic stroke hospitalisation, Stroke and Vascular Neurology, 10.1136/svn-2021-001170, (svn-2021-001170) Related articlesGuidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke AssociationWilliam J. Powers, et al. Stroke. 2019;50:e344-e418 December 2019Vol 50, Issue 12 Advertisement Article InformationMetrics © 2019 American Heart Association, Inc.https://doi.org/10.1161/STR.0000000000000215PMID: 31765293 Originally publishedNovember 25, 2019 PDF download Advertisement